Health Care

Roche lymphoma drug drives high remission rate, longer survival: Study

An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

Philippines wants money back from Sanofi for dengue vaccine

The Philippine health chief says the government will demand a refund of more than 3 billion pesos ($59 million) from Sanofi Pasteur and look at possible legal action after a study showed its dengue vaccine the country used in an immunization program could expose some people to severe illness.

More than 2,000 drugs now in cancer immunotherapy race

The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.